The University of Southampton
University of Southampton Institutional Repository

The implementation of a hepatitis C testing service in community pharmacies: I-COPTIC consensus statement

The implementation of a hepatitis C testing service in community pharmacies: I-COPTIC consensus statement
The implementation of a hepatitis C testing service in community pharmacies: I-COPTIC consensus statement
Objectives: this aimed to develop a blueprint for an effective community pharmacy Hepatitis C virus (HCV) testing service by producing a consensus statement.

Study design: this was a modified Delphi process.

Methods: we recruited a heterogenous panel of experts (who had been involved in the setup or delivery of a community pharmacy HCV testing service) by purposive and chain referral methods. We had three rounds of a modified Delphi process. The first was a series of questions with free text responses and was analysed using thematic analysis, and the second and third were statements for the respondents to rate using a 7-point Likert scale. Consensus was predefined in a published protocol, and the results were reviewed by a public and patient involvement panel before the statement was finalised.

Results: we had 24 participants, including community and hospital-based pharmacists, local pharmaceutical committee members, charity representatives (Hepatitis C Trust), local clinical service lead, nurse specialists and doctors. The response rate of the first, second and third rounds were 100%, 96% and 88%, respectively. After the third round, we had 60 statements that reached consensus. We discussed the accepted statements with a patient and public involvement group. We used these statements to produce the I-COPTIC statement and a graphical summary.

Conclusions: we developed a blueprint for the design of a gold standard community pharmacy HCV testing service. We believe this will support the successful implementation of community pharmacy testing for HCV. Community pharmacy testing is an important service to help achieve and maintain HCV elimination.
0033-3506
153-160
Cook, C.
85b6be1f-823b-4f2b-9b4f-dc787fc4f037
Reid, L.
4a07c6df-a382-4333-87b6-78d8543533bd
Elsharkawy, A.M.
9f68fe40-a632-4fab-ada6-f50f2fe9c7a4
Radley, A.
3057aa41-4be9-4649-afb6-eaa71f77ce6c
Smith, S.
73bc8f2c-884c-49a3-b39e-50cfefff78cc
Mcpherson, S.
e5101fdd-1ca4-4864-b603-5ea0a2363f11
Crockford, D.
8039e920-ccb3-4dec-a671-39ad22b2f84c
Dillon, J.F.
20705ee1-dc06-4334-8e1a-60fc7fb5bf1d
Wright, M.
a2208784-9495-4710-95f6-f2f1dd7d2374
Morris, D.
90ec0bee-30d8-484d-9a55-bb88a782f67b
Malik, H.
829bca8e-1b58-4a9c-bba2-f6652e3a76ea
Keall, S.
3017fae2-0f70-4471-b3f4-0da31f71ed3b
Powell, J.
49871236-d6a7-40dd-9950-a8565efa1a19
Catt, J.
7a7053f5-104b-4857-b3ed-debefcaf689d
Hampton, H.
8485e283-1a11-430b-a856-ab89f7f5e51f
Boothman, H.
d138f3a3-8c2b-40c9-88ff-de85000e07e9
Shah, S.
a6840f7d-84e5-4733-a1d8-35a3c64ee621
Spear, J.
f22c2d52-9db6-4c5f-a168-51ca1c904cd5
Ustianoski, A.
90f8fef8-1538-48df-9926-31f7d9f56297
John, P.
275e1465-5972-43db-b880-9e65d25d8da1
Stevens, H.
0057292f-f821-4f7a-a6bb-3ff5dc1e4b92
Khakoo, S.I.
6c16d2f5-ae80-4d9b-9100-6bfb34ad0273
Parkes, J.
59dc6de3-4018-415e-bb99-13552f97e984
Buchanan, R.M.
a092c890-492a-478f-8d13-0453d482a700
et al.
Cook, C.
85b6be1f-823b-4f2b-9b4f-dc787fc4f037
Reid, L.
4a07c6df-a382-4333-87b6-78d8543533bd
Elsharkawy, A.M.
9f68fe40-a632-4fab-ada6-f50f2fe9c7a4
Radley, A.
3057aa41-4be9-4649-afb6-eaa71f77ce6c
Smith, S.
73bc8f2c-884c-49a3-b39e-50cfefff78cc
Mcpherson, S.
e5101fdd-1ca4-4864-b603-5ea0a2363f11
Crockford, D.
8039e920-ccb3-4dec-a671-39ad22b2f84c
Dillon, J.F.
20705ee1-dc06-4334-8e1a-60fc7fb5bf1d
Wright, M.
a2208784-9495-4710-95f6-f2f1dd7d2374
Morris, D.
90ec0bee-30d8-484d-9a55-bb88a782f67b
Malik, H.
829bca8e-1b58-4a9c-bba2-f6652e3a76ea
Keall, S.
3017fae2-0f70-4471-b3f4-0da31f71ed3b
Powell, J.
49871236-d6a7-40dd-9950-a8565efa1a19
Catt, J.
7a7053f5-104b-4857-b3ed-debefcaf689d
Hampton, H.
8485e283-1a11-430b-a856-ab89f7f5e51f
Boothman, H.
d138f3a3-8c2b-40c9-88ff-de85000e07e9
Shah, S.
a6840f7d-84e5-4733-a1d8-35a3c64ee621
Spear, J.
f22c2d52-9db6-4c5f-a168-51ca1c904cd5
Ustianoski, A.
90f8fef8-1538-48df-9926-31f7d9f56297
John, P.
275e1465-5972-43db-b880-9e65d25d8da1
Stevens, H.
0057292f-f821-4f7a-a6bb-3ff5dc1e4b92
Khakoo, S.I.
6c16d2f5-ae80-4d9b-9100-6bfb34ad0273
Parkes, J.
59dc6de3-4018-415e-bb99-13552f97e984
Buchanan, R.M.
a092c890-492a-478f-8d13-0453d482a700

Cook, C., Reid, L. and Elsharkawy, A.M. , et al. (2024) The implementation of a hepatitis C testing service in community pharmacies: I-COPTIC consensus statement. Public Health, 232, 153-160. (doi:10.1016/j.puhe.2024.04.017).

Record type: Article

Abstract

Objectives: this aimed to develop a blueprint for an effective community pharmacy Hepatitis C virus (HCV) testing service by producing a consensus statement.

Study design: this was a modified Delphi process.

Methods: we recruited a heterogenous panel of experts (who had been involved in the setup or delivery of a community pharmacy HCV testing service) by purposive and chain referral methods. We had three rounds of a modified Delphi process. The first was a series of questions with free text responses and was analysed using thematic analysis, and the second and third were statements for the respondents to rate using a 7-point Likert scale. Consensus was predefined in a published protocol, and the results were reviewed by a public and patient involvement panel before the statement was finalised.

Results: we had 24 participants, including community and hospital-based pharmacists, local pharmaceutical committee members, charity representatives (Hepatitis C Trust), local clinical service lead, nurse specialists and doctors. The response rate of the first, second and third rounds were 100%, 96% and 88%, respectively. After the third round, we had 60 statements that reached consensus. We discussed the accepted statements with a patient and public involvement group. We used these statements to produce the I-COPTIC statement and a graphical summary.

Conclusions: we developed a blueprint for the design of a gold standard community pharmacy HCV testing service. We believe this will support the successful implementation of community pharmacy testing for HCV. Community pharmacy testing is an important service to help achieve and maintain HCV elimination.

This record has no associated files available for download.

More information

Accepted/In Press date: 9 April 2024
e-pub ahead of print date: 22 May 2024
Published date: 22 May 2024

Identifiers

Local EPrints ID: 499246
URI: http://eprints.soton.ac.uk/id/eprint/499246
ISSN: 0033-3506
PURE UUID: 08419b4a-a9b3-429b-9ec5-80e8cab6ab29
ORCID for S.I. Khakoo: ORCID iD orcid.org/0000-0002-4057-9091
ORCID for J. Parkes: ORCID iD orcid.org/0000-0002-6490-395X

Catalogue record

Date deposited: 12 Mar 2025 17:53
Last modified: 13 Mar 2025 02:38

Export record

Altmetrics

Contributors

Author: C. Cook
Author: L. Reid
Author: A.M. Elsharkawy
Author: A. Radley
Author: S. Smith
Author: S. Mcpherson
Author: D. Crockford
Author: J.F. Dillon
Author: M. Wright
Author: D. Morris
Author: H. Malik
Author: S. Keall
Author: J. Powell
Author: J. Catt
Author: H. Hampton
Author: H. Boothman
Author: S. Shah
Author: J. Spear
Author: A. Ustianoski
Author: P. John
Author: H. Stevens
Author: S.I. Khakoo ORCID iD
Author: J. Parkes ORCID iD
Author: R.M. Buchanan
Corporate Author: et al.

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×